Article
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium.
Journal of gastroenterology and hepatology - 1 Jun 2022
Banerjee Rupa, Pal Partha, Hilmi Ida, Ghoshal Uday C, Desai Devendra C, Rahman Mohammed Masudur, Dutta Usha, Mohiuddin Syed A, Al Mohannadi Munnera, Philip Mathew, Ramesh Ganesh N, Niriella Madunil A, De Silva Arjuna P, de Silva Hithanadura Janaka, Pisespongsa Pises, Limsrivilai Julajak, Aniwan Satimai, Nawarathne Metthananda, Fernandopulle Nilesh, Aye Than Than, Ni Nwe, Al Awadhi Sameer, Joshi Neeraj, Ngoc Pham Thi V, Kieu Tuan V, Nguyen Anh Duong, Abdullah Murdani, Ali Ezzat, Zeid Ahmed, Sollano Jose D, Saberi Bismillah, Omar Mahmoud, Mohsin Mostafa Noor, Aftab Hafeza, Wai Tin Moe, Shastri Yogesh M, Chaudhuri Sujit, Ahmed Faruque, Bhatia Shobna J, Travis Simon P L
Abstract excerpt
BACKGROUND AND AIM: Inflammatory bowel disease (IBD) is emerging in the newly industrialized countries of South Asia, South-East Asia, and the Middle East, yet epidemiological data are scarce. METHODS: We performed a cross-sectional study of IBD demographics, disease phenotype, and treatment across 38 centers in 15 countries of South Asia, South-East Asia, and Middle East. Intergroup comparisons included gross...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.